HI
TAK icon

Harbour Investments’s Takeda Pharmaceutical TAK Stock Holding History

Harbour Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
8,107
+3,495
+76% +$61.3K ﹤0.01% 1689
2025
Q4 		$71.9K Buy
4,612
+3,460
+300% +$49.5K ﹤0.01% 1794
2025
Q3 		$16.9K Sell
1,152
-224
-16% -$3.33K ﹤0.01% 2441
2025
Q2 		$21.3K Hold
1,376
– – ﹤0.01% 2204
2025
Q1 		$20.5K Sell
1,376
-377
-22% -$5.28K ﹤0.01% 2181
2024
Q4 		$23.2K Hold
1,753
– – ﹤0.01% 2060
2024
Q3 		$24.9K Hold
1,753
– – ﹤0.01% 1960
2024
Q2 		$22.7K Sell
1,753
-285
-14% -$3.77K ﹤0.01% 1899
2024
Q1 		$28.3K Buy
2,038
+377
+23% +$5.48K ﹤0.01% 1787
2023
Q4 		$23.7K Buy
1,661
+55
+3% +$780 ﹤0.01% 1792
2023
Q3 		$24.8K Sell
1,606
-33
-2% -$511 ﹤0.01% 1650
2023
Q2 		$25.7K Buy
1,639
+1,211
+283% +$19.8K ﹤0.01% 1659
2023
Q1 		$7.05K Sell
428
-70
-14% -$1.11K ﹤0.01% 2164
2022
Q4 		$7.77K Hold
498
– – ﹤0.01% 2061
2022
Q3 		$7K Hold
498
– – ﹤0.01% 2079
2022
Q2 		$7K Buy
+498
New +$7.11K ﹤0.01% 2079
2021
Q4 		$6K Sell
424
-4,016
-90% -$56.3K ﹤0.01% 2134
2021
Q3 		$73K Sell
4,440
-212
-5% -$3.56K ﹤0.01% 1548
2021
Q2 		$78K Buy
4,652
+212
+5% +$3.61K ﹤0.01% 1541
2021
Q1 		$81K Buy
+4,440
New +$79.9K ﹤0.01% 1417

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments's TAK Position: Q1 2026 in Review

Harbour Investments increased its Takeda Pharmaceutical (TAK) stake by 76% in Q1 2026, buying an estimated $61.3K and bringing the position to 8,107 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

Harbour Investments first reported a position in TAK in Q1 2021 and has held it in 20 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Harbour Investments held 8,107 shares of Takeda Pharmaceutical worth $150K as of Q1 2026.
  • Harbour Investments bought 3,495 Takeda Pharmaceutical shares in Q1 2026, an estimated $61.3K.
  • Takeda Pharmaceutical made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1689 holding.
  • Harbour Investments first reported a position in Takeda Pharmaceutical in Q1 2021 and has held it in 20 quarters since.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.